PPA
SRNE

Parametric Portfolio Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Parametric Portfolio Associates’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$306K Buy
131,423
+31,149
+31% +$97.2K ﹤0.01% 3267
2021
Q4 		$466K Sell
100,274
-1,642
-2% -$10.2K ﹤0.01% 3103
2021
Q3 		$778K Sell
101,916
-39,223
-28% -$333K ﹤0.01% 2907
2021
Q2 		$1.37M Buy
141,139
+8,251
+6% +$65.7K ﹤0.01% 2638
2021
Q1 		$1.1M Buy
132,888
+23,331
+21% +$246K ﹤0.01% 3123
2020
Q4 		$748K Buy
109,557
+57,213
+109% +$460K ﹤0.01% 3192
2020
Q3 		$584K Buy
52,344
+7,106
+16% +$65K ﹤0.01% 3197
2020
Q2 		$284K Buy
45,238
+17,060
+61% +$65.3K ﹤0.01% 3493
2020
Q1 		$52K Sell
28,178
-1,640
-6% -$4.72K ﹤0.01% 3833
2019
Q4 		$101K Sell
29,818
-153,414
-84% -$366K ﹤0.01% 3859
2019
Q3 		$392K Sell
183,232
-129,174
-41% -$301K ﹤0.01% 3428
2019
Q2 		$834K Buy
312,406
+5,608
+2% +$20.2K ﹤0.01% 3142
2019
Q1 		$1.46M Buy
+306,798
New +$805K ﹤0.01% 2832
2018
Q4 		– Sell
-20,500
Closed -$90K – 3983
2018
Q3 		$90K Sell
20,500
-33,077
-62% -$183K ﹤0.01% 3857
2018
Q2 		$386K Buy
+53,577
New +$364K ﹤0.01% 3454
2015
Q3 		– Sell
-10,430
Closed -$184K – 3354
2015
Q2 		$184K Buy
+10,430
New +$134K ﹤0.01% 3787

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Parametric Portfolio Associates's SRNE Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Sorrento Therapeutics, Inc. (SRNE) stake by 31% in Q1 2022, buying an estimated $97.2K and bringing the position to 131,423 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #3267.

Parametric Portfolio Associates first reported a position in SRNE in Q2 2015 and has held it in 16 quarters since. The position peaked at $1.46M in Q1 2019. 235 funds tracked by Wall St. Rank hold SRNE as of Q1 2022.

  • Parametric Portfolio Associates held 131,423 shares of Sorrento Therapeutics, Inc. worth $306K as of Q1 2022.
  • Parametric Portfolio Associates bought 31,149 Sorrento Therapeutics, Inc. shares in Q1 2022, an estimated $97.2K.
  • Sorrento Therapeutics, Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3267 holding.
  • Parametric Portfolio Associates first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and has held it in 16 quarters since.
  • Parametric Portfolio Associates's Sorrento Therapeutics, Inc. position peaked at $1.46M in Q1 2019.
  • 235 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.